Heterojunction engineered bioactive chlorella for cascade promoted cancer therapy
Top Cited Papers
- 2 April 2022
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 345, 755-769
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31922042, 32071322, 81771966, 81801826)
- Fundamental Research Funds for the Central Universities (2019PT320028, 2020-RC320-002, 2021-RC310-005)
This publication has 62 references indexed in Scilit:
- Chlorella sorokiniana-Induced Activation and Maturation of Human Monocyte-Derived Dendritic Cells through NF-κB and PI3K/MAPK PathwaysEvidence-Based Complementary and Alternative Medicine, 2012
- A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell deathThe EMBO Journal, 2012
- Photoactivation switch from type II to type I reactions by electron-rich micelles for improved photodynamic therapy of cancer cells under hypoxiaJournal of Controlled Release, 2011
- Bacteria-Induced Gap Junctions in Tumors Favor Antigen Cross-Presentation and Antitumor ImmunityScience Translational Medicine, 2010
- Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and OptimizationChemical Reviews, 2010
- Immunostimulatory Bioactivity of Algal Polysaccharides fromChlorella pyrenoidosaActivates Macrophages via Toll-Like Receptor 4Journal of Agricultural and Food Chemistry, 2009
- Intra‐tumoral Salmonella typhimurium induces a systemic anti‐tumor immune response that is directed by low‐dose radiation to treat distal diseaseEuropean Journal of Immunology, 2008
- Cancer despite immunosurveillance: immunoselection and immunosubversionNature Reviews Immunology, 2006
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Photodynamic therapy for cancerNature Reviews Cancer, 2003